Downloads provided by UsageCounts
handle: 10261/242943
La presente invención se refiere a una serie de compuestos con un núcleo estructural de benzotiazol-benzamida que tienen capacidad para inhibir la enzima LRRK2, por lo que la invención también se refiere al uso de estos compuestos para el tratamiento de enfermedades neurodegenerativas en las que esta enzima está implicada, tales como la enfermedad de Parkinson o la enfermedad de Alzheimer. [ES]
The present invention relates to a series of compounds having a structural benzothiazole-benzamide core with capacity to inhibit the LRRK2 enzyme, due to which the invention also relates to the use of these compounds for treating neurodegenerative diseases in which this enzyme is involved, such as Parkinson's Disease or Alzheimer's Disease. [IN]
A1 Solicitud de patente con informe sobre el estado de la técnica
Consejo Superior de Investigaciones Científicas (España)
Peer reviewed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 34 | |
| downloads | 50 |

Views provided by UsageCounts
Downloads provided by UsageCounts